Concord Medical Services Holdings (CCM) - Total Liabilities
Based on the latest financial reports, Concord Medical Services Holdings (CCM) has total liabilities worth $4.70 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Concord Medical Services Holdings (CCM) net asset momentum to track the company's year-over-year net asset growth rate.
Concord Medical Services Holdings - Total Liabilities Trend (2007–2025)
This chart illustrates how Concord Medical Services Holdings's total liabilities have evolved over time, based on quarterly financial data. See CCM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Concord Medical Services Holdings Competitors by Total Liabilities
The table below lists competitors of Concord Medical Services Holdings ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Greencore Group
LSE:GNC
|
UK | GBX780.70 Million |
|
Nosa Med AB
ST:NOSA
|
Sweden | Skr23.65 Million |
|
EcoBio Holdings Co. Ltd
KQ:038870
|
Korea | ₩34.64 Billion |
|
ES Australia Israel Holdings Ltd
TA:AUIS
|
Israel | ILA423.97 Million |
|
Energys Group Limited Ordinary Shares
NASDAQ:ENGS
|
USA | $10.36 Million |
|
Argenica Therapeutics Ltd
AU:AGN
|
Australia | AU$1.76 Million |
|
Samyoung S&C Co. Ltd.
KQ:361670
|
Korea | ₩2.85 Billion |
|
CNPLUS Co. Ltd.
KQ:115530
|
Korea | ₩47.39 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Concord Medical Services Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CCM market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Concord Medical Services Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Concord Medical Services Holdings (2007–2025)
The table below shows the annual total liabilities of Concord Medical Services Holdings from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.70 Billion | -8.05% |
| 2024-12-31 | $5.11 Billion | +18.61% |
| 2023-12-31 | $4.31 Billion | +7.96% |
| 2022-12-31 | $3.99 Billion | +14.43% |
| 2021-12-31 | $3.49 Billion | +18.83% |
| 2020-12-31 | $2.93 Billion | +21.82% |
| 2019-12-31 | $2.41 Billion | +4.18% |
| 2018-12-31 | $2.31 Billion | -5.67% |
| 2017-12-31 | $2.45 Billion | +22.72% |
| 2016-12-31 | $2.00 Billion | -7.81% |
| 2015-12-31 | $2.17 Billion | +86.84% |
| 2014-12-31 | $1.16 Billion | -29.73% |
| 2013-12-31 | $1.65 Billion | +29.56% |
| 2012-12-31 | $1.27 Billion | +258.35% |
| 2011-12-31 | $355.35 Million | -2.70% |
| 2010-12-31 | $365.21 Million | +25.88% |
| 2009-12-31 | $290.12 Million | -69.44% |
| 2008-12-31 | $949.38 Million | +4574.65% |
| 2007-12-31 | $20.31 Million | -- |
About Concord Medical Services Holdings
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other tre… Read more